Stalevo is an anti-parkinsonian dopaminergic combination medication that contains carbidopa levodopa and entacapone for the treatment of Parkinson’s disease. It is marketed by Swiss-based Novartis Pharmaceuticals and manufactured by Finnish drugmaker Orion Corporation.
This page contains content from the copyrighted Wikipedia article "Stalevo"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
